ResMed
RMD
322 hedge funds and large institutions have $4.52B invested in ResMed in 2013 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 105 increasing their positions, 128 reducing their positions, and 36 closing their positions.
33% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 36
16% more capital invested
Capital invested by funds: $3.9B → $4.52B (+$622M)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
3% more funds holding
Funds holding: 313 → 322 (+9)
15.82% less ownership
Funds ownership: 78.51% → 62.69% (-16%)
18% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 128
64% less call options, than puts
Call options by funds: $47.2M | Put options by funds: $130M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$139M |
| 2 |
Renaissance Technologies
New York
|
+$33.6M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$32.1M |
| 4 |
RIM
Rainier Investment Management
Seattle,
Washington
|
+$31.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$19.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WBC
Westpac Banking Corp
Sydney,
Australia
|
-$1.3B |
| 2 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$96.4M |
| 3 |
LCG
Luxor Capital Group
New York
|
-$37.2M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$21.4M |
| 5 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$12M |
RMD Hedge Fund Activity: Q3 2013 in Review
322 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2013, worth a combined $4.52B — up 16% from $3.9B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new RMD positions and 36 closed out — a net gain of 12 holders — while 105 added to existing stakes and 128 trimmed.
The largest buyer was Invesco, adding an estimated $139M. The largest seller was Westpac Banking Corp, cutting an estimated $1.3B.
- 322 institutional investors held ResMed (RMD) as of Q3 2013, up from 313 in Q2 2013.
- Funds reported $4.52B of ResMed stock for Q3 2013, up 16% quarter-over-quarter.
- 48 funds opened new ResMed positions in Q3 2013 and 36 closed out, a net change of +12 holders.
- The largest ResMed buyer in Q3 2013 was Invesco, an estimated $139M added.
- The largest ResMed seller in Q3 2013 was Westpac Banking Corp, an estimated $1.3B sold.
Based on aggregated 13F filings for Q3 2013.